| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |